Blood Journal
Leading the way in experimental and clinical research in hematology

HLA-haploidentical bone marrow transplantation with post-transplant cyclophosphamide expands the donor pool for patients with sickle cell disease

  1. Javier Bolaños-Meade1,*,
  2. Ephraim J. Fuchs1,
  3. Leo Luznik1,
  4. Sophie M. Lanzkron2,
  5. Christopher J. Gamper3,
  6. Richard J. Jones1, and
  7. Robert A. Brodsky2
  1. 1 Hematologic Malignancies and Bone Marrow Transplantation Program, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, MD, United States;
  2. 2 Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States;
  3. 3 Division of Pediatric Oncology, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, MD, United States
  1. * Corresponding author; email: fbolano2{at}jhmi.edu

To view this item, select one of the options below

If you already have a subscription, you may gain access using your ASH username and password.

Sign In for Institutional Administrators

If you are a Librarian or institutional account administrator you can use this link to manage your account and view usage reports.

 

Purchase Short-Term Access

Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00.
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

OpenAthens Users

Log in through your institution

Sign Up

Subscribe to the Journal - Subscribe to the print and/or online journal.

Access for Patients

Access for Patients - Patients desiring access should contact the journal.